Published in Immunol Today on January 01, 1993
Humoral immune responses in CD40 ligand-deficient mice. J Exp Med (1994) 3.32
Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol Rev (1995) 3.12
Cytokine-mediated regulation of chronic intestinal helminth infection. J Exp Med (1994) 2.90
Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J Virol (1994) 2.07
Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease. J Exp Med (1996) 1.91
Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest (1996) 1.74
Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1999) 1.62
Cytokine production in the immune response to murine gammaherpesvirus 68. J Virol (1996) 1.61
T-cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of lyme disease. Infect Immun (2000) 1.60
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function. J Clin Invest (2001) 1.53
Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus. J Virol (2000) 1.44
Interleukin-9 enhances resistance to the intestinal nematode Trichuris muris. Infect Immun (1998) 1.42
An early CD4+ T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions. J Exp Med (2003) 1.40
Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J Exp Med (2003) 1.38
Position-dependent inhibition of class-switch recombination by PGK-neor cassettes inserted into the immunoglobulin heavy chain constant region locus. Proc Natl Acad Sci U S A (1999) 1.36
The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc Natl Acad Sci U S A (1995) 1.35
B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J Exp Med (1996) 1.34
Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes. Mol Med (1995) 1.26
Heterogeneity in the differentiation and function of memory B cells. Trends Immunol (2012) 1.25
Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (2000) 1.21
Interferon gamma-producing gammadelta T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection. Proc Natl Acad Sci U S A (1998) 1.17
Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective. J Virol (1995) 1.17
Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection. Infect Immun (1996) 1.17
Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse. J Exp Med (1996) 1.13
Activated murine B lymphocytes and dendritic cells produce a novel CC chemokine which acts selectively on activated T cells. J Exp Med (1998) 1.12
Aberrant T-cell function in vitro and impaired T-cell dependent antibody response in vivo in vitamin A-deficient rats. Immunology (1993) 1.11
High pathogenic potential of low-affinity autoantibodies in experimental autoimmune hemolytic anemia. J Exp Med (1999) 1.09
Negative immunodiffusion test results obtained with sera of paracoccidioidomycosis patients may be related to low-avidity immunoglobulin G2 antibodies directed against carbohydrate epitopes. Clin Diagn Lab Immunol (2003) 1.07
Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol (2010) 1.07
Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice. J Exp Med (1996) 1.06
CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infect Immun (2000) 1.05
Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization. Proc Natl Acad Sci U S A (2000) 1.01
Interleukin-4-dependent immunoglobulin G1 isotype switch in the presence of a polarized antigen-specific Th1-cell response to the trypanosome variant surface glycoprotein. Infect Immun (1998) 1.01
The cytotoxic T-lymphocyte response to Sendai virus is unimpaired in the absence of gamma interferon. J Virol (1997) 1.00
Differential requirements for an intact spleen in induction and expression of B-cell-dependent immunity to Plasmodium chabaudi AS. Infect Immun (1994) 1.00
The regulation and role of T follicular helper cells in immunity. Immunology (2011) 0.99
Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii. Infect Immun (2001) 0.96
Down-regulation of core 1 beta1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1. Nephrol Dial Transplant (2010) 0.96
Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology. J Virol (2015) 0.91
Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo. Infect Immun (1998) 0.91
Neisserial porins may provide critical second signals to polysaccharide-activated murine B cells for induction of immunoglobulin secretion. Infect Immun (1997) 0.90
Global structures of IgG isotypes expressing identical variable regions. Mol Immunol (2013) 0.90
Acute and chronic phases of Toxoplasma gondii infection in mice modulate the host immune responses. Infect Immun (1998) 0.90
Clonal variants of hybridoma cells that switch isotype at a high frequency. Proc Natl Acad Sci U S A (1994) 0.89
Profiles of immunoregulatory cytokine production in vitro in patients with IgA nephropathy and their kindred. Clin Exp Immunol (1994) 0.89
Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals. Clin Exp Immunol (1998) 0.88
Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J Virol (1999) 0.86
Human IgG subclass responses and subclass restriction to Schistosoma mansoni egg antigens. Immunology (1994) 0.86
Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection. Immunology (2002) 0.85
Repeat bacterial challenge in a subcutaneous chamber model results in augmented tumour necrosis factor-alpha and interferon-gamma response, and suppression of interleukin-10. Immunology (2000) 0.84
Intranasal antigen targeting to MHC class II molecules primes local IgA and serum IgG antibody responses in mice. Immunology (1997) 0.84
Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies. Immunology (2006) 0.83
TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm. Clin Exp Immunol (2004) 0.82
Inflammatory monocytes are critical for induction of a polysaccharide-specific antibody response to an intact bacterium. J Immunol (2012) 0.82
Human IgA-inducing protein from dendritic cells induces IgA production by naive IgD+ B cells. J Immunol (2009) 0.82
IgG subclass co-expression brings harmony to the quartet model of murine IgG function. Immunol Cell Biol (2016) 0.82
Dietary intake of resveratrol enhances the adaptive immunity of aged rats. Rejuvenation Res (2012) 0.81
Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice. Immunology (2000) 0.80
Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen. J Extracell Vesicles (2014) 0.80
Rejuvenating activity of salidroside (SDS): dietary intake of SDS enhances the immune response of aged rats. Age (Dordr) (2012) 0.80
Preventative effect of an herbal preparation (HemoHIM) on development of airway inflammation in mice via modulation of Th1/2 cells differentiation. PLoS One (2013) 0.80
IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy. Immunology (1994) 0.80
Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats. Clin Exp Immunol (2001) 0.79
Regulation of thymus-dependent and thymus-independent production of immunoglobulin G subclasses by Galpha12 and Galpha13. J Mol Signal (2008) 0.78
Multiparameter flow cytometry and bioanalytics for B cell profiling in systemic lupus erythematosus. Methods Mol Biol (2012) 0.78
Fasciola gigantica fatty acid binding protein (FABP) as a prophylactic agent against Schistosoma mansoni infection in CD1 mice. Korean J Parasitol (2012) 0.78
Roles of major histocompatibility complex class II in inducing protective immune responses to influenza vaccination. J Virol (2014) 0.77
Mucosal adjuvanticity of fibronectin-binding peptide (FBP) fused with Echinococcus multilocularis tetraspanin 3: systemic and local antibody responses. PLoS Negl Trop Dis (2012) 0.77
Retinol binding protein and vitamin D associations with serum antibody isotypes, serum influenza virus-specific neutralizing activities and airway cytokine profiles. Clin Exp Immunol (2015) 0.76
Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells. Clin Exp Immunol (2006) 0.76
Effects of Allergina on the treatment of otitis media with effusions. Inflammation (2002) 0.75
Efficiency of pH-sensitive fusogenic polymer-modified liposomes as a vaccine carrier. ScientificWorldJournal (2013) 0.75
Assessment of safety and the immune response to the CD4 "internal antigen" mouse anti-idiotypic Mab 16D7 in four patients with SLE. J Clin Immunol (2002) 0.75
Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science (1987) 13.03
Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. Proc Natl Acad Sci U S A (1986) 4.69
T cell-independent antigens type 2. Annu Rev Immunol (1995) 4.62
Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. Proc Natl Acad Sci U S A (1991) 3.57
Persistent calcium elevation correlates with the induction of surface immunoglobulin-mediated B cell DNA synthesis. J Exp Med (1993) 2.88
Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med (1998) 2.78
Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol Rev (1977) 2.50
Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med (1992) 2.47
Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function. J Exp Med (1985) 2.27
Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin. J Immunol (1981) 2.26
Inability of mice with a defect in B-lymphocyte maturation to respond to phosphorycholine on immunogenic carriers. J Exp Med (1977) 2.18
B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev (2000) 2.17
T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus. Eur J Immunol (1978) 2.13
The ontogeny of thymic independent antibody responses in vitro in normal mice and mice with an X-linked B cell defect. J Immunol (1977) 2.03
Polyclonal activation of the murine immune system by an antibody to IgD. II. Generation of polyclonal antibody production and cells with surface IgG. J Immunol (1982) 1.96
Picogram quantities of anti-Ig antibodies coupled to dextran induce B cell proliferation. J Immunol (1988) 1.84
Polyclonal activation of the murine immune system by a goat antibody to mouse IgD. IX. Induction of a polyclonal IgE response. J Immunol (1987) 1.82
T cell independent antigens. Curr Opin Immunol (1995) 1.78
Role of T lymphocytes in the response to TNP-AECM-Ficoll. J Immunol (1980) 1.66
B cell stimulatory factor-1 (interleukin 4) prepares resting murine B cells to secrete IgG1 upon subsequent stimulation with bacterial lipopolysaccharide. J Immunol (1987) 1.66
Interferon-gamma suppresses B cell stimulation factor (BSF-1) induction of class II MHC determinants on B cells. J Immunol (1986) 1.66
CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol (1992) 1.62
Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody. J Immunol (1985) 1.60
Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J Exp Med (1993) 1.56
A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J Immunol (1996) 1.56
Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents. Vaccine (1996) 1.51
Production of BSF-1 during an in vivo, T-dependent immune response. J Immunol (1986) 1.47
Novel in vitro model for high-rate IgA class switching. J Immunol (1995) 1.41
B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline CH transcription and Ig class switching. J Immunol (1997) 1.38
Early development of the T cell repertoire. In vivo treatment of neonatal mice with anti-Ia antibodies interferes with differentiation of I-restricted T cells but not K/D-restricted T cells. J Exp Med (1983) 1.35
Immune response to levan. III. The capacity to produce anti-inulin antibodies and cross-reactive idiotypes appears late in ontogeny. J Immunol (1979) 1.34
Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. J Biol Chem (1988) 1.33
Role of the thymus in directing the development of a subset of B lymphocytes. J Exp Med (1982) 1.32
Interferon-gamma inhibits the action of B cell stimulatory factor (BSF)-1 on resting B cells. J Immunol (1986) 1.32
Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence. J Immunol (1991) 1.29
B cell stimulatory factor 1 (BSF-1) prepares resting B cells to enter S phase in response to anti-IgM and lipopolysaccharide. J Exp Med (1986) 1.27
In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties. J Immunol (1986) 1.27
IgE class switching is critically dependent upon the nature of the B cell activator, in addition to the presence of IL-4. J Immunol (1991) 1.27
T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells. J Immunol (1985) 1.26
IL-4 induction of IgE class switching by lipopolysaccharide-activated murine B cells occurs predominantly through sequential switching. J Immunol (1993) 1.24
Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation. J Immunol (1992) 1.21
Role of a nonimmunoglobulin cell surface determinant in the activation of B lymphocytes by thymus-independent antigens. J Exp Med (1979) 1.19
Surface immunoglobulin crosslinking activates a tyrosine kinase pathway in B cells that is independent of protein kinase C. Proc Natl Acad Sci U S A (1991) 1.19
"Numatrin," a nuclear matrix protein associated with induction of proliferation in B lymphocytes. J Biol Chem (1987) 1.17
Use of the T lymphocyte regulated type 2 antigens for the analysis of responsiveness of Lyb5+ and Lyb5- B lymphocytes to T lymphocyte derived factors. Immunol Rev (1982) 1.16
Polyclonal activation of the murine immune system by an antibody to IgD. I. Increase in cell size and DNA synthesis. J Immunol (1982) 1.16
Regulation of 3' IgH enhancers by a common set of factors, including kappa B-binding proteins. J Immunol (1996) 1.15
T lymphocyte-dependent B lymphocyte proliferative response to antigen. I Genetic restriction of the stimulation of B lymphocyte proliferation. J Exp Med (1981) 1.15
Distinct types of T-cell help for the induction of a humoral immune response to Streptococcus pneumoniae. Trends Immunol (2001) 1.13
B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae. J Immunol (2000) 1.11
The importance of theta and Ig hearing cells in the immune response to various antigens. J Immunol (1971) 1.10
In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions. J Immunol (1999) 1.10
Size-dependent B lymphocyte subpopulations: relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP-Ficoll and TNP-BA. J Immunol (1984) 1.10
Analysis of B cell activation requirements with TNP-conjugated polyacrylamide beads. J Immunol (1979) 1.10
Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population. J Immunol (1983) 1.08
Affinity-purified interleukin 2 induces proliferation of large but not small B cells. Proc Natl Acad Sci U S A (1985) 1.06
Heterogeneity of Ia expression on normal B cells, neonatal B cells, and on cells from B cell-defective CBA/N mice. J Immunol (1980) 1.06
Induction of primary and inhibition of secondary antibody response to hapten by hapten conjugates of type III pneumococcal polysaccharide. Cell Immunol (1975) 1.06
Greater sensitivity to inhibition by anti-immunoglobulin of splenic than of bone marrow B-lymphocytes. J Immunol (1973) 1.05
Comparative in vitro analysis of proliferation, Ig secretion, and Ig class switching by murine marginal zone and follicular B cells. J Immunol (1993) 1.05
T helper cells grown with hapten-modified cultured Langerhans' cells produce interleukin 4 and stimulate IgE production by B cells. Eur J Immunol (1989) 1.05
Thymus-derived cell (T cell) activation by heterologous antigens as a replacement of specific immune T cells in the transfer of the secondary response to sheep erythrocytes. J Exp Med (1972) 1.05
Kinetics of B cell memory development during a thymus "independent" immune response. Cell Immunol (1974) 1.04
Surface antigens of immunocompetent cells. IV. Effect of anti-b5 allotype on immunologic responses of homozygous b5 rabbit cells in vitro. J Immunol (1972) 1.03
An in vitro model for T cell-independent induction of humoral immunity. A requirement for NK cells. J Immunol (1994) 1.03
Surface immunoglobulin-mediated B-cell activation in the absence of detectable elevations in intracellular ionized calcium: a model for T-cell-independent B-cell activation. Proc Natl Acad Sci U S A (1989) 1.02
IL-10 selectively regulates murine Ig isotype switching. Int Immunol (1996) 1.01
Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody. J Immunol (1983) 0.98
The p65 subunit of NF-kappa B is redundant with p50 during B cell proliferative responses, and is required for germline CH transcription and class switching to IgG3. J Immunol (1999) 0.98
Natural killer cells induce activated murine B cells to secrete Ig. J Immunol (1993) 0.98
Synergistic genetic defect in B-lymphocyte function. I. Defective responses to B-cell stimulants and their genetic basis. J Exp Med (1980) 0.96
Bacterial lipoproteins may substitute for cytokines in the humoral immune response to T cell-independent type II antigens. J Immunol (1995) 0.94
IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. J Immunol (1993) 0.93
Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cells. J Immunol (1987) 0.93
Corticosteroid induction of Ig+Ia- B cells in vitro is mediated via interaction with the glucocorticoid cytoplasmic receptor. J Immunol (1988) 0.93
Different patterns of inositol polyphosphate production are seen in B lymphocytes after cross-linking of sIg by anti-Ig antibody or by a multivalent anti-Ig antibody dextran conjugate. J Immunol (1989) 0.92
Neonatal suppression with anti-Ia antibody. I. Suppression of murine B lymphocyte development. J Immunol (1982) 0.92
Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2. Infect Immun (1998) 0.92
Biochemical analysis of the immune B cell defect in xid mice. J Immunol (1991) 0.91
Evidence for DNA binding activity of numatrin (B23), a cell cycle-regulated nuclear matrix protein. Biochim Biophys Acta (1990) 0.91
Polyclonal activation of the murine immune system by an antibody to IgD. VIII. Stimulation of IgD secretion. J Immunol (1987) 0.91
Neisserial porins may provide critical second signals to polysaccharide-activated murine B cells for induction of immunoglobulin secretion. Infect Immun (1997) 0.90
Prospects for vaccines during pregnancy and in the newborn period. Clin Perinatol (1997) 0.90
Lymphokine control of type 2 antigen response. IL-10 inhibits IL-5- but not IL-2-induced Ig secretion by T cell-independent antigens. J Immunol (1992) 0.89
Antibody affinity in mice with the CBA/N defect. J Immunol (1980) 0.89
Effects of cholera toxin on human B cells. Cholera toxin induces B cell surface DR expression while it inhibits anti-mu antibody-induced cell proliferation. J Immunol (1990) 0.89